UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3379-3385

2015

Volltextzugriff (PDF)

Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?

Breast cancer research and treatment, 2023-06, Vol.199 (2), p.215-220

2023

Volltextzugriff (PDF)

106 Cumulative Cancer Location Incidence and Cancer Progression in an Active Surveillance Cohort

Journal of clinical and translational science, 2022-04, Vol.6 (s1), p.2-2

2022

Volltextzugriff (PDF)

MP17-01 HETEROGENEITY IN DETECTION RATES OF HIGHER GRADE PROSTATE CANCER BY MULTIPARAMETRIC MRI IN AN ACTIVE SURVEILLANCE COHORT

The Journal of urology, 2018-04, Vol.199 (4), p.e205-e205

2018

Volltextzugriff (PDF)

MP15-08 IS PSA DENSITY OR PSA (OR NEITHER) USEFUL TO PREDICT BIOPSY RECLASSIFICATION IN ACTIVE SURVEILLANCE PATIENTS?

The Journal of urology, 2016-04, Vol.195 (4), p.e154-e155

2016

Volltextzugriff (PDF)

IMPACT OF SOCIAL DISTANCING DURING THE SARS-COV-2 PANDEMIC ON THE ASSOCIATION BETWEEN VIRAL RESPIRATORY ILLNESS AND CARDIOVASCULAR-RELATED EVENTS

Chest, 2022-10, Vol.162 (4), p.A285-A285

2022

Volltextzugriff (PDF)

PD26-03 THE EFFECT OF PROSTATE VOLUME ON GRADE PROGRESSION AND TREATMENT DECISIONS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER ON ACTIVE SURVEILLANCE

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

MP43-01 CLINICAL SIGNIFICANCE OF DETECTION OF PERINEURAL INVASION IN LOW-RISK MEN ON ACTIVE SURVEILLANCE

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

MP43-04 COMPARISON OF 4K SCORE, PROSTATE HEALTH INDEX, AND PSA DENSITY IN ACTIVE SURVEILLANCE

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

MP38-04 BASELINE PROSTATE HEALTH INDEX RISK CATEGORY AND RISK CATEGORY CHANGES DURING ACTIVE SURVEILLANCE PREDICT GRADE RECLASSIFICATION

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

PD17-07 IS CONFIRMATORY BIOPSY STILL NECESSARY IN MEN WITH GRADE GROUP 1 PROSTATE CANCER IN THE MULTIPARAMETRIC MRI ERA?

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

MP62-16 PROSTATE CANCER RADIOLOGICAL ESTIMATION OF CHANGE IN SEQUENTIAL EVALUATION (PRECISE) SCORING TO PREDICT CLINICAL OUTCOMES IN ACTIVE SURVEILLANCE OF PROSTATE CANCER

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

PD26-08 IMPACT OF HIGH-RISK FAMILY HISTORY ON UPGRADING DURING ACTIVE SURVEILLANCE FOR GRADE GROUP 1 PROSTATE CANCER—RESULTS FROM THE JOHNS HOPKINS ACTIVE SURVEILLANCE REGISTRY

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

PD26-06 ASSOCIATION BETWEEN DIET AND NUTRIENT INTAKE AND UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

MP43-17 PREDICTING TRUE PATHOLOGIC GLEASON GRADE DURING ACTIVE SURVEILLANCE FOR PROSTATE CANCER: CALIBRATION OF THE JOHNS HOPKINS ACTIVECARE MODEL IN FIVE LARGE ACTIVE SURVEILLANCE COHORTS

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

MP32-03 ASSOCIATION BETWEEN SPECIFIC ASPECTS OF DIET AND INFLAMMATORY POTENTIAL AND BIOPSY UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

MP62-14 TRANSPERINEAL PROSTATE BIOPSY IMPROVES THE DETECTION OF GRADE GROUP 3 OR HIGHER PROSTATE CANCER AMONG MEN ON ACTIVE SURVEILLANCE

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Volltextzugriff (PDF)

MP9-02 OLDER AGE PREDICTS GLEASON SCORE UPGRADING DURING LONG-TERM MONITORING ON ACTIVE SURVEILLANCE

The Journal of urology, 2015, Vol.193 (4), p.e102-e102

2015

Volltextzugriff (PDF)

Comparison of biochemical recurrence free survival after radical prostatectomy triggered by grade reclassification on active surveillance, and men newly diagnosed with similar grade disease

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5047-5047

2017

Volltextzugriff (PDF)

PD55-07 VERY LOW RISK AND LOW RISK PATIENTS IN ACTIVE SURVEILLANCE: IS THE DISTINCTION RELEVANT?

The Journal of urology, 2017-04, Vol.197 (4), p.e1053-e1053

2017

Volltextzugriff (PDF)

MP43-13 COMPARISON OF BIOCHEMICAL RECURRENCE FREE SURVIVAL AFTER RADICAL PROSTATECTOMY AMONG MEN IN ACTIVE SURVEILLANCE FOLLOWING GRADE RECLASSIFICATION AND MEN NEWLY DIAGNOSED WITH SIMILAR GRADE DISEASE

The Journal of urology, 2017-04, Vol.197 (4), p.e558-e559

2017

Volltextzugriff (PDF)

Comparison of biochemical recurrence-free survival after radical prostatectomy among men in active surveillance following grade reclassification and men newly diagnosed with similar grade disease

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.117-117

2017

Volltextzugriff (PDF)

MP66-02 NUMBER OF BIOPSY CORES CONTAINING GRADE GROUP 2 IS PROGNOSTIC FOR ADVERSE PATHOLOGIC FEATURES AND PROSTATE CANCER RECURRENCE

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

MP48-09 GRADE RECLASSIFICATION IN ACTIVE SURVEILLANCE FOR AFRICAN AMERICAN MEN WITH VERY LOW RISK PROSTATE CANCER

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

MP66-03 AMONG MEN WITH GLEASON GRADE GROUP 3, INTERMEDIATE-RISK PROSTATE CANCER, STAGE CT2 IS ASSOCIATED WITH METASTATIC RECURRENCE

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Aktive Filter

ThemaUrology & Nephrology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(68)

Sprache

Englisch
(68)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Urology
(15)
Humans
(11)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Covid-19
(9)
Adult
(8)
Covid-19 - Prevention & Control
(8)
Covid-19 Vaccines
(8)
Hospitalization
(8)
Mrna Vaccines
(7)
Severe Acute Respiratory Syndrome Coronavirus 2
(7)
Mrna
(6)
Coronaviruses
(5)
Covid-19 - Epidemiology
(5)
Immunization
(5)
Infectious Diseases
(5)
Vaccination
(5)
Vaccine Efficacy
(5)
Adults
(4)
Infections
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer

Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?

106 Cumulative Cancer Location Incidence and Cancer Progression in an Active Surveillance Cohort

MP17-01 HETEROGENEITY IN DETECTION RATES OF HIGHER GRADE PROSTATE CANCER BY MULTIPARAMETRIC MRI IN AN ACTIVE SURVEILLANCE COHORT

MP15-08 IS PSA DENSITY OR PSA (OR NEITHER) USEFUL TO PREDICT BIOPSY RECLASSIFICATION IN ACTIVE SURVEILLANCE PATIENTS?

IMPACT OF SOCIAL DISTANCING DURING THE SARS-COV-2 PANDEMIC ON THE ASSOCIATION BETWEEN VIRAL RESPIRATORY ILLNESS AND CARDIOVASCULAR-RELATED EVENTS

PD26-03 THE EFFECT OF PROSTATE VOLUME ON GRADE PROGRESSION AND TREATMENT DECISIONS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER ON ACTIVE SURVEILLANCE

MP43-01 CLINICAL SIGNIFICANCE OF DETECTION OF PERINEURAL INVASION IN LOW-RISK MEN ON ACTIVE SURVEILLANCE

MP43-04 COMPARISON OF 4K SCORE, PROSTATE HEALTH INDEX, AND PSA DENSITY IN ACTIVE SURVEILLANCE

MP38-04 BASELINE PROSTATE HEALTH INDEX RISK CATEGORY AND RISK CATEGORY CHANGES DURING ACTIVE SURVEILLANCE PREDICT GRADE RECLASSIFICATION

PD17-07 IS CONFIRMATORY BIOPSY STILL NECESSARY IN MEN WITH GRADE GROUP 1 PROSTATE CANCER IN THE MULTIPARAMETRIC MRI ERA?

MP62-16 PROSTATE CANCER RADIOLOGICAL ESTIMATION OF CHANGE IN SEQUENTIAL EVALUATION (PRECISE) SCORING TO PREDICT CLINICAL OUTCOMES IN ACTIVE SURVEILLANCE OF PROSTATE CANCER

PD26-08 IMPACT OF HIGH-RISK FAMILY HISTORY ON UPGRADING DURING ACTIVE SURVEILLANCE FOR GRADE GROUP 1 PROSTATE CANCER—RESULTS FROM THE JOHNS HOPKINS ACTIVE SURVEILLANCE REGISTRY

PD26-06 ASSOCIATION BETWEEN DIET AND NUTRIENT INTAKE AND UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE

MP43-17 PREDICTING TRUE PATHOLOGIC GLEASON GRADE DURING ACTIVE SURVEILLANCE FOR PROSTATE CANCER: CALIBRATION OF THE JOHNS HOPKINS ACTIVECARE MODEL IN FIVE LARGE ACTIVE SURVEILLANCE COHORTS

MP32-03 ASSOCIATION BETWEEN SPECIFIC ASPECTS OF DIET AND INFLAMMATORY POTENTIAL AND BIOPSY UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE

MP62-14 TRANSPERINEAL PROSTATE BIOPSY IMPROVES THE DETECTION OF GRADE GROUP 3 OR HIGHER PROSTATE CANCER AMONG MEN ON ACTIVE SURVEILLANCE

MP9-02 OLDER AGE PREDICTS GLEASON SCORE UPGRADING DURING LONG-TERM MONITORING ON ACTIVE SURVEILLANCE

Comparison of biochemical recurrence free survival after radical prostatectomy triggered by grade reclassification on active surveillance, and men newly diagnosed with similar grade disease

PD55-07 VERY LOW RISK AND LOW RISK PATIENTS IN ACTIVE SURVEILLANCE: IS THE DISTINCTION RELEVANT?

MP43-13 COMPARISON OF BIOCHEMICAL RECURRENCE FREE SURVIVAL AFTER RADICAL PROSTATECTOMY AMONG MEN IN ACTIVE SURVEILLANCE FOLLOWING GRADE RECLASSIFICATION AND MEN NEWLY DIAGNOSED WITH SIMILAR GRADE DISEASE

Comparison of biochemical recurrence-free survival after radical prostatectomy among men in active surveillance following grade reclassification and men newly diagnosed with similar grade disease

MP66-02 NUMBER OF BIOPSY CORES CONTAINING GRADE GROUP 2 IS PROGNOSTIC FOR ADVERSE PATHOLOGIC FEATURES AND PROSTATE CANCER RECURRENCE

MP48-09 GRADE RECLASSIFICATION IN ACTIVE SURVEILLANCE FOR AFRICAN AMERICAN MEN WITH VERY LOW RISK PROSTATE CANCER

MP66-03 AMONG MEN WITH GLEASON GRADE GROUP 3, INTERMEDIATE-RISK PROSTATE CANCER, STAGE CT2 IS ASSOCIATED WITH METASTATIC RECURRENCE

Aktive Filter

Suchergebnisse filtern